FIBRINOGEN: Prophylactic trials: intervention vs haemostatically active control
Arterial thromboembolic events at 1 to 2 years · the prevention and treatment of bleeding in patients without haemophilia
1 finding from 1 review
- Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 49 participantsLow